Medical and technological innovation, as well as changes in public health and demographics, present new opportunities for growth, but also a need for prioritization. Oslo Economics has competence within:
- Pharmaceuticals, device and market access
- Biostatistics and research dissemination
- Analysis of real world evidence (RWE)
- Burden of disease and cost of illness (COI)
- HR, personnel costs and labor market analyses
- Analysis of sectors and ripple effects
- Capital budgeting and concept selection for hospitals
- Organizing and patient flow
- Public-private cooperation
- Innovation and the health industry
